中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2015年
17期
32-33
,共2页
慢性阻塞性肺疾病%急性加重期%痰热清注射液%血气指标%临床疗效
慢性阻塞性肺疾病%急性加重期%痰熱清註射液%血氣指標%臨床療效
만성조새성폐질병%급성가중기%담열청주사액%혈기지표%림상료효
Chronic obstructive pulmonary disease%Acute exacerbation%Tanreqing injection%Blood gas%Clinical effect
目的 观察痰热清注射液治疗慢性阻塞性肺疾病急性加重期(AECOPD)的临床疗效.方法 选取郑州大学附属洛阳中心医院收治的AECOPD患者92例作为研究对象,随机将患者分为对照组和观察组,对照组行常规治疗,观察组在对照组基础上取痰热清注射液治疗,观察治疗前后白细胞计数、中性粒子细胞、C-反应蛋白(CRP)、肺功能指标等的变化,并评估临床疗效.结果 观察组治疗有效率为89.13％,显著高于对照组71.74％,差异具有统计学意义(P＜0.05).观察组治疗后CRP为(10.16±3.21) mg/L显著低于对照组(17.20±4.51)mg/L,差异具有统计学意义(P＜0.05).观察组1秒用力呼气容积(FEVl)、用力肺活量(FVC)、FEVl/FVC(FEVl％)分别为(1.62±0.60)L、(2.63±1.12)L、(63.26±9.84)％,显著高于对照组,差异具有统计学意义(P＜0.05).结论 在常规治疗的基础上辅以痰热清注射液治疗AECOPD,能够改善患者肺功能,提高临床疗效.
目的 觀察痰熱清註射液治療慢性阻塞性肺疾病急性加重期(AECOPD)的臨床療效.方法 選取鄭州大學附屬洛暘中心醫院收治的AECOPD患者92例作為研究對象,隨機將患者分為對照組和觀察組,對照組行常規治療,觀察組在對照組基礎上取痰熱清註射液治療,觀察治療前後白細胞計數、中性粒子細胞、C-反應蛋白(CRP)、肺功能指標等的變化,併評估臨床療效.結果 觀察組治療有效率為89.13％,顯著高于對照組71.74％,差異具有統計學意義(P＜0.05).觀察組治療後CRP為(10.16±3.21) mg/L顯著低于對照組(17.20±4.51)mg/L,差異具有統計學意義(P＜0.05).觀察組1秒用力呼氣容積(FEVl)、用力肺活量(FVC)、FEVl/FVC(FEVl％)分彆為(1.62±0.60)L、(2.63±1.12)L、(63.26±9.84)％,顯著高于對照組,差異具有統計學意義(P＜0.05).結論 在常規治療的基礎上輔以痰熱清註射液治療AECOPD,能夠改善患者肺功能,提高臨床療效.
목적 관찰담열청주사액치료만성조새성폐질병급성가중기(AECOPD)적림상료효.방법 선취정주대학부속락양중심의원수치적AECOPD환자92례작위연구대상,수궤장환자분위대조조화관찰조,대조조행상규치료,관찰조재대조조기출상취담열청주사액치료,관찰치료전후백세포계수、중성입자세포、C-반응단백(CRP)、폐공능지표등적변화,병평고림상료효.결과 관찰조치료유효솔위89.13％,현저고우대조조71.74％,차이구유통계학의의(P＜0.05).관찰조치료후CRP위(10.16±3.21) mg/L현저저우대조조(17.20±4.51)mg/L,차이구유통계학의의(P＜0.05).관찰조1초용력호기용적(FEVl)、용력폐활량(FVC)、FEVl/FVC(FEVl％)분별위(1.62±0.60)L、(2.63±1.12)L、(63.26±9.84)％,현저고우대조조,차이구유통계학의의(P＜0.05).결론 재상규치료적기출상보이담열청주사액치료AECOPD,능구개선환자폐공능,제고림상료효.
Objective To observe the clinical curative effect of taureqing injection on acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods Ninety-two AECOPD patients admitted to the hospital as the research objects,they were randomly divided into observation group and control group,the control group received routine treatment,the observation group took Tanreqing injection on the basis of the control group,the changes of white blood cell count,neutrophil cells,C reactive protein,lung function indicators,and evaluation of clinical efficacy before and after treatment were observed.Results The effective rate of the observation group (89.13％) was significantly higher than that in the control group (71.74％),there was significant difference (P ＜0.05).The observation group after treatment,CRP [(10.16 ±3.21) mg/L] was significantly lower than that of control group [(17.20 ±4.51) mg/L],there was significant difference (P＜0.05).In observation group,FEV1,FVC and FEV1/FVC were (1.62 ±0.60) L,(2.63 ± 1.12) L,(63.26 ± 9.84) ％,which were significantly higher than those in control group,the differences were significant (P ＜ 0.05).Conclusions On the basis of conventional therapy,Tanreqing injection in treatment of AECOPD can improve pulmonary function,improve clinical curative effect.
